2023
DOI: 10.1007/s10557-023-07516-2
|View full text |Cite
|
Sign up to set email alerts
|

Contemporary Medical Management of Peripheral Arterial Disease

Ian O. Cook,
Jayer Chung
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 100 publications
0
1
0
Order By: Relevance
“…The novel role of PLXND1 and KLF2 as vascular caliber regulators suggests that variants in these genes could contribute to diseases involving reduced vascular calibers, myocardial ischemia [173,174], peripheral artery disease [175], atherosclerosis [29], hypertension [176], diabetes [177], and glaucoma [178]. Thus, increasing the expression or activity of Plexin D1 and KLF2 might therapeutically enhance the blood flow in individuals afflicted by these conditions and in patients with congenital heart defects suffering from impaired cardiac blood flow.…”
Section: Discussionmentioning
confidence: 99%
“…The novel role of PLXND1 and KLF2 as vascular caliber regulators suggests that variants in these genes could contribute to diseases involving reduced vascular calibers, myocardial ischemia [173,174], peripheral artery disease [175], atherosclerosis [29], hypertension [176], diabetes [177], and glaucoma [178]. Thus, increasing the expression or activity of Plexin D1 and KLF2 might therapeutically enhance the blood flow in individuals afflicted by these conditions and in patients with congenital heart defects suffering from impaired cardiac blood flow.…”
Section: Discussionmentioning
confidence: 99%